4-bromo-6-nitroquipazine: A new ligand for studying 5-hydroxytryptamine uptake sites in vivo
- 1 September 1992
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 31 (9) , 869-874
- https://doi.org/10.1016/0028-3908(92)90124-8
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Reduction of [3H]6‐nitroquipazine‐labelled 5‐hydroxytryptamine uptake sites in rat brain by 3,4‐methylenedioxymethamphetamineFundamental & Clinical Pharmacology, 1990
- Reduction of in vivo binding of [3H]paroxetine in mouse brain by 3,4-methylenedioxymethamphetamineNeuropharmacology, 1990
- Neurochemistry and Neurotoxicity of 3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”)Journal of Neurochemistry, 1990
- In Vivo Labeling of Serotonin Uptake Sites with [3H]ParoxetineJournal of Neurochemistry, 1989
- Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administrationBrain Research, 1988
- Aminergic systems in Alzheimer's disease and Parkinson's diseaseAnnals of Neurology, 1987
- Decreased Imipramine Binding in the Brains of Patients with Depressive IllnessThe British Journal of Psychiatry, 1983
- Tritiated Imipramine Binding Sites Are Decreased in the Frontal Cortex of SuicidesScience, 1982
- Distribution of Specific High‐Affinity Binding Sites for [3H]Imipramine in Human BrainJournal of Neurochemistry, 1981
- Specific tricyclic antidepressant binding sites in rat brainNature, 1979